Clinical Trial: Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple Sclerosis

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762040) titled 'Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple Sclerosis' on July 29.

Brief Summary: The goal of this prospective observational cohort study is to determine the frequency of progression independent of relapse activity (PIRA) and identify its clinical, radiological, neuroaxonal, and functional predictors in patients with early relapsing-remitting multiple sclerosis (RRMS). The study aims to facilitate early identification of patients at increased risk of disability progression independent of relapses and to support individualized therapeutic decision-making.

The main questions it aims to an...